Constipation and bowel obstruction

Similar documents
Constipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment

Nausea and Vomiting in Palliative Care

Identify electrolytes that should be monitored whenever prolonged or severe diarrhea is present

Constipation. What is constipation? What is the criteria for having constipation? What are the different types of constipation?

Opioid Induced Constipation Lisa Clince Acute Pain CNS Palmerston North Hospital

Chapter 31 Bowel Elimination

Constipation an Old Friend. Presented by Dr. Keith Harris

OPIOID-INDUCED CONSTIPATION DR ANDREW DAVIES

Multimodal Approach for Managing Postoperative Ileus: Role of Health- System Pharmacists (ACPE program H01P)

Drugs Affecting the Gastrointestinal System. Antidiarrheal and Laxatives

Using Evidence Based Medicine to Ethically Provide End of Life Symptom Control

Aging Persons with Intellectual Developmental Disorders (IDD): Constipation KEYPOINTS OVERVIEW

daily; available as 10- mg g PO

Postoperative Ileus. UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011

What else is new (other symptoms) DR ANDREW DAVIES

SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL

Syringe driver in Palliative Care

Elderly Man With Chronic Constipation

Authors and Disclosures

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Gastrointestinal obstruction in palliative care: a review

Antidiarrheals Antidiarrheal

Nursing Principles & Skills II. Bowel Sounds Constipation Fecal Impaction

Is one of the most common chronic disorders. causing patients to seek medical treatment.

PAIN MANAGEMENT Person established taking oral morphine or opioid naive.

What Is Constipation?

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Movantik (naloxegol), Relistor (methylnaltrexone bromide)

Gastrointestinal obstruction Dr Iain Lawrie

ALVIMOPAN 0.0 OVERVIEW

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club

Understanding & Alleviating Constipation. Living (Well!) with Gastroparesis Program Warm-Up Class

Clinical problems related to GI involvement in SSc

Effectiveness and Tolerability of Amidotrizoate for the Treatment of Constipation Resistant to Laxatives in Advanced Cancer Patients

ABC of palliative care: Constipation and diarrhoea

GI Physiology - Investigating and treating patients with pelvic floor dysfunction. Lynne Smith Department of GI Physiology NGH Sheffield

Chapter 41. Media Directory. Lower Digestive Tract. Constipation (continued) Constipation

Health Learning Partnership End of Life Care 29 th June 2016

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine)

Common Gastrointestinal Problems in the Elderly

CENTENE PHARMACY AND THERAPEUTICS DRUG REVIEW 3Q17 July August

Management of the Neurogenic Bowel. June st National SBAA Conference Bloomington, Minnesota

11/04/2011 OVERVIEW. Neurogenic Bowel Management. in adults with Spinal Cord Injury (S.C.I.) Sequence of events in normal Defecation

10/08/59 CAUSES OF BOWEL OBSTRUCTION IN MALIGNANCY INCIDENCE OF BOWEL OBSTRUCTION BEWARE! SYMPTOM PROFILE RADIOLOGY

Agitation Excessive physical or mental restlessness. Increased activity that is generally not purposeful and associated with anxiety.

Supplementary Appendix

Nausea & Vomiting. Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA

Advances in Palliative Care

FOOT OFF THE BRAKES. Kerri Novak MD MSc FRCPC. Chronic Constipation: Taking the Foot off the Brakes Dr. Kerri Novak

Opioid-induced constipation a preventable problem

Constipation. H. David Vargas, MD. Overview

encathopedia Volume 8 NEUROGENIC BOWEL DYSFUNCTION AND TAI

Amitiza. Amitiza (lubiprostone) Description

CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University

MOVICOL HALF PI December MOVICOL-Half. Powder for Solution (macrogol 3350) Potassium 5.4 mmol/l. Bicarbonate 17 mmol/l

Second term/

MOVICOL Junior Powder for Solution (macrogol 3350)

Hemorrhoids. Carlos R. Alvarez-Allende PGY-III Colorectal Surgery

Palliative care for patients with brain cancer

Constipation. Disease Review

Management of Neurogenic Bowel Dysfunction. Fiona Paul, DNP, RN, CPNP Center for Motility and Functional Gastrointestinal Disorders

15. Prevention of UTI and lifestyle modifications

CONSTIPATION. Atan Baas Sinuhaji

Gastrointestinal. Issues in ElderCare. TCHP Education. Consortium. Part of the ElderCare: Healthcare for the Aging Series

Chapter 19. Assisting With Bowel Elimination. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Pharmacology. Drugs that Affect the Gastrointestinal System

Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)

Protectives and Adsorbents. Inorganic chemistry Course 1 Third year Assist. Lecturer Ahlam A. Shafeeq MSc. Pharmaceutical chemistry

SUPPLEMENTARY INFORMATION Associated with

Instruct patient and caregivers: Need for constant monitoring Potential complications of drug therapy

The Digestive System or tract extends from the mouth to the anus.

Pharmacy Benefit Determination Policy

Chronic constipation in the elderly

Chapter 34. Nursing Care of Patients with Lower Gastrointestinal Disorders

We would like to thank you for completing this audit questionnaire which looks at how you manage nausea and vomiting in palliative care patients.

Oral Methylnaltrexone for the. Constipation in Patients with Chronic Non-cancer Pain

Constipation. Self-study course

Chapter 22. Bowel Needs. Copyright 2019 by Elsevier, Inc. All rights reserved.

SYMPROIC (naldemedine tosylate) oral capsule

3/22/2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease Objectives: Appendicitis. Lemone and Burke Chapter 26

MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350)

MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350)

Prof. Dr. Mufti Munsurar Rahman Dept. of Medicine Enam Medical College Hospital

Developing spinal cord compression care guidelines at WPH

Functional constipation in children: which treatment is effective and safe? An evidence-based case report

Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Primary Care Constipation Guidelines. Version 1 November 2016

Fecal Incontinence. What is fecal incontinence?

STRATEGIES TO IMPROVE ENTERAL FEEDING TOLERANCE. IS IT WORTH IT? ENGELA FRANCIS RD(SA)

The term inflammatory bowel disease is used to designate two related inflammatory intestinal disorders:

COMMON PROBLEMS IN PAEDIATRIC GASTROENTEROLOGY AKSHAY BATRA CONSULTANT PAEDIATRIC GASTROENTEROLOGIST

Movantik (naloxegol), Relistor (methylnaltrexone bromide), Symproic (naldemedine)

Developing spinal cord compression care guidelines at WPH

Constipation Information Leaflet THE DIGESTIVE SYSTEM. gutscharity.org.uk

Objectives Brand name Generic name Primary indication, drug classes Dosage forms Patient counseling information Important side effects and contraindic

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Narcotic Analgesics. Jacqueline Morgan March 22, 2017

Chronic Abdominal Pain. Dr. Robert B. Smith Tupelo Digestive Health Specialists August 26, 2016

Bowel Function After Spinal Cord Injury

SUMMARY OF THE PRODUCT CHARACTERISTICS. The content of electrolyte ions per sachet when made up to 125 ml of solution.

Transcription:

Constipation and bowel obstruction

Constipation Infrequent or difficult defecation with reduced number of bowel movements, which may or may not be abnormally hard with increased difficulty or discomfort

Constipation One of the most common complaints- in general population 1,9-27,2%, more than 50% od patients in palliative care unit In pallitive care the constipation should be defined according to patients experience

Causes of constipation

Primary causes Intestinal abnormality Tumor compression Neural plexus invasion Idiopathic constipation

Secondary causes Electrolyte imbalance (hypercalemia, hyperkalemia) Endocrine abnormality (hypothyroidism, diabetes mellitus) Neurogenic disorders (multiple sclerosis, spinal cor injury) Drugs (analgetics-opioids, anticholinergic) Other causes (dehydratation, immobility, decreased oral intake)

Assessment History of the previous normal bowel habits Defining pattern of change in terms of frequency, consistency, straining, drug history, associated symptoms Subjective measuresof constipation- VAS Physical examination: abdominal auscultation, inspection, palpation, percussion, digital rectal examination Check for correctable reasons- electrolyte imbalance, endocrine disorders

Management-prevention Patient education Increase dietary and fluid intake Prophylaxis laxatives when initiating opioids Increase mobility Confortable environment for defecation

Pharmacotherapy Oral laxatives: Emollients Bulk-forming agents Osmotic agents Hyperosmolar agents Contact cathartics Prokinetic drugs Opioid antagonists

Pharmacotherapy Rectal preparations (unpleasant, but quick results) Suppositories Enemas

Opioid antagonists Opioid-induced constipation mediated by mu receptors in GI system Methylnaltrexone- restricted ability to cross the blood-brain barrier and does not affect opioid analgesic effects

Nonpharmacological approach Methodes used in prevention Biofeedback

Constipation Can present as pseudo-diarrheaalways perform DRE! Discontinue constipating drugs when possible Fiber supplements should be discouraged

Bowel obstruction Common and distressing complication of intraabdominal cancer Mechanical obstruction or failure of normal intestinal motility in the absence of an obstructing lesion Flow: partial/complete bowel obstruction Intestinal ischemia: simple/strangulated Site: small intestine/colonic Once malignant bowel obstruction occurs median survival is approximately 3 months

Causes

Clinical presentation Depending on : location, single/multiple points of obstruction, mechanism, exacerbating medications

Clinical presentation Symptoms: - Nausea - Vomiting-early in high intestinal tract occlusion, later in patients with large bowel obstruction - Intestinal colic -Continous abdominal pain- more than 90% of the patients - Absence of stool and flatus passage

Diagnosis and assessment History and medical exam Laboratory and imageing data Differential diagnoses

Management Symptoms relief!!!

Surgical approach Disease stage Patients condition Possibility of future therapy More benefitial for patients with life expectancy>2 months Benefitial for patients with mechanical obstruction/limited tumor

Nonsurgical approach Drainage with a nasogastric tube- great discomfort, many complications Drugs: analgetics, antiemetic, drugs decreasing bowel secretion Also: anticholinergic, steroids, smooth muscle relaxants Most patients do not tolerate oral routeconsider alternative routes

Drugs Opioids- most effective drugs for management of abdominal pain, sc, td,iv Anticholinergic drugs like scopolamine (hioscine)- gold standard- can be added to opioids for colicky pain, also reduce bowel secretion sc, iv Corticosteroids- reducing intestinal and tumor-associated edema Metoclopramide- only in partial bowel obstruction, in the absence of colicky pain, contraindicated in complete obstruction Haloperidol- first line antiemetic- central, can be added to morphine and scopolamine butylbromide